Filtered By:
Therapy: Hormonal Therapy
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 218 results found since Jan 2013.
Hormone Therapy Linked to CV Risk During Gender Transition Hormone Therapy Linked to CV Risk During Gender Transition
Transgender hormone therapy is associated with an increased risk for MI, stroke, and venous thromboembolism, underscoring the importance of patient counseling and close monitoring in this population.Medscape Medical News
Source: Medscape Medical News Headlines - February 20, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news
Increase stroke risk in transgender women receiving hormone therapy
Research, published inCirculation, suggests that hormone therapy increases the risk of stroke in transgender women.Healio
Source: Society for Endocrinology - February 20, 2019 Category: Endocrinology Source Type: news
Hormone therapy in postmenopausal women associated with risk of stroke and venous thromboembolism: a population-based cohort study in Taiwan
Conclusions:
In postmenopausal Taiwanese women, HT may be associated with an increased risk of cardiovascular disease. Although the women in our population receiving HT were near menopausal age, their risk of cardiovascular disease was still higher than in the non-HT group.
Source: Menopause - January 29, 2019 Category: OBGYN Tags: Original Articles Source Type: research
The 2017 hormone therapy position statement of The North American Menopause Society
The 2017 Hormone Therapy Position Statement of The North American Menopause Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The North American Menopause Society and identifies future research needs. An Advisory Panel of clinicians and researchers expert in the field of women's health and menopause was recruited by NAMS to review the 2012 Position Statement, evaluate new literature, assess the evidence, and reach consensus on recommendations, using the level of evidence to identify the strength of recommendations and the quality of the evidence. The Panel's recommendations were reviewed and approved by...
Source: Menopause - October 25, 2018 Category: OBGYN Tags: Commemorative Papers Source Type: research
Pattern of mortality after menopausal hormone therapy: long-term follow-up in a population based cohort.
CONCLUSIONS: In this long-term follow-up study, taking hormones during menopause was not associated with overall mortality among middle-aged women. Investigating cause-specific mortality revealed significant albeit weak associations differential according to both causes of death and over time underlining the importance of carefully considering individual risks and duration of treatment when making decisions on hormone therapy. This article is protected by copyright. All rights reserved.
PMID: 30106241 [PubMed - as supplied by publisher]
Source: BJOG : An International Journal of Obstetrics and Gynaecology - August 14, 2018 Category: OBGYN Authors: Holm M, Olsen A, Au Yeung SL, Overvad K, Lidegaard Ø, Kroman N, Tjønneland A Tags: BJOG Source Type: research
Cardiovascular health in transgender people
AbstractThis review examines the relationship between exogenous sex steroids and cardiovascular events and surrogate markers in trans (transgender) people. Data from trans populations is compared to data from postmenopausal women and hypogonadal men when appropriate. In an age-adjusted comparison with cisgender people, trans people appear to have an increased risk for myocardial infarction and death due to cardiovascular disease. It is uncertain whether hormone therapy in trans people affects their risk of stroke. In studies that followed trans people on hormone therapy, the rates of myocardial infarction and stroke were c...
Source: Reviews in Endocrine and Metabolic Disorders - August 3, 2018 Category: Endocrinology Source Type: research
Cardiovascular health in transgender people.
Abstract
This review examines the relationship between exogenous sex steroids and cardiovascular events and surrogate markers in trans (transgender) people. Data from trans populations is compared to data from postmenopausal women and hypogonadal men when appropriate. In an age-adjusted comparison with cisgender people, trans people appear to have an increased risk for myocardial infarction and death due to cardiovascular disease. It is uncertain whether hormone therapy in trans people affects their risk of stroke. In studies that followed trans people on hormone therapy, the rates of myocardial infarction and str...
Source: ENDOCR REV - August 3, 2018 Category: Endocrinology Authors: Irwig MS Tags: Rev Endocr Metab Disord Source Type: research
Cardiovascular health in transgender people
AbstractThis review examines the relationship between exogenous sex steroids and cardiovascular events and surrogate markers in trans (transgender) people. Data from trans populations is compared to data from postmenopausal women and hypogonadal men when appropriate. In an age-adjusted comparison with cisgender people, trans people appear to have an increased risk for myocardial infarction and death due to cardiovascular disease. It is uncertain whether hormone therapy in trans people affects their risk of stroke. In studies that followed trans people on hormone therapy, the rates of myocardial infarction and stroke were c...
Source: Reviews in Endocrine and Metabolic Disorders - August 3, 2018 Category: Endocrinology Source Type: research
Hormone therapy in menopausal women with fibroids: is it safe?
Menopause is an important transition in the life of women. It has been estimated that by the year 2030, worldwide 1.2 billion women will be menopausal. The most bothersome symptoms of menopause are believed to be due to declines in estrogen levels in postmenopausal women. Thus, hormone therapy is an effective treatment option for menopausal women, although prolonged use of hormone therapy is associated with a slightly increased risk of breast cancer, thromboembolism, and stroke. A literature search for studies evaluating the effects of hormone therapy in menopausal women with asymptomatic fibroids demonstrated variable eff...
Source: Menopause - July 26, 2018 Category: OBGYN Tags: Personal Perspective Source Type: research
Heart Risks Tied to Transwomen ' s Hormone Therapy
TUESDAY, July 10, 2018 -- Transwomen who undergo hormone therapy may face higher chances of blood clots, stroke and heart attack, a new study suggests.
The term transwoman refers to a woman who is designated male at birth. Some undergo hormone...
Source: Drugs.com - Daily MedNews - July 10, 2018 Category: General Medicine Source Type: news
Hormone therapy in transgender women may deteriorate cardiovascular health
Hormone treatment given to transgender patients transitioning from male to female may significantly increase their risk of stroke, a study inAnnals of Internal Medicine reports. Reuters
Source: Society for Endocrinology - July 10, 2018 Category: Endocrinology Source Type: news
Hormone therapy poses stroke risk for transgender women
Hormones given to people to align their sex with their gender pose a significant risk of serious blood clots and stroke among transgender women.
Source: PsycPORT.com - July 10, 2018 Category: Psychiatry Source Type: news
Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
Conclusion: The patterns of increases in VTE and ischemic stroke rates among transfeminine persons are not consistent with those observed in cisgender women. These results may indicate the need for long-term vigilance in identifying vascular side effects of cross-sex estrogen.
Primary Funding Source: Patient-Centered Outcomes Research Institute and Eunice Kennedy Shriver National Institute of Child Health and Human Development.
PMID: 29987313 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - July 10, 2018 Category: Internal Medicine Authors: Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, Hunkeler E, Lash TL, Millman A, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Safer J, Slovis J, Tangpricha V, Goodman M Tags: Ann Intern Med Source Type: research
Hormone therapy poses stroke risk for transgender women
(Reuters Health) - Hormones given to people to align their sex with their gender pose a significant risk of serious blood clots and stroke among transgender women, one of the largest studies of transgender patients has concluded.
Source: Reuters: Health - July 9, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Stroke Risk Factors Unique to Women
According to this study:
Optimal stroke prevention strategies for women should take into account risk factors specific to women, including endogenous hormone levels, exogenous hormone therapy, and pregnancy-related complications.
Source: AJN - April 26, 2018 Category: Nursing Tags: Journal Watch Source Type: research
